KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBT Margin (2016 - 2025)

Historic EBT Margin for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 41.03%.

  • Amgen's EBT Margin rose 45600.0% to 41.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.92%, marking a year-over-year increase of 85400.0%. This contributed to the annual value of 13.79% for FY2024, which is 140700.0% down from last year.
  • Amgen's EBT Margin amounted to 41.03% in Q3 2025, which was up 45600.0% from 17.08% recorded in Q2 2025.
  • Amgen's EBT Margin's 5-year high stood at 56.38% during Q1 2023, with a 5-year trough of 0.91% in Q1 2024.
  • For the 5-year period, Amgen's EBT Margin averaged around 24.68%, with its median value being 25.56% (2022).
  • Per our database at Business Quant, Amgen's EBT Margin surged by 295300bps in 2023 and then tumbled by -572900bps in 2024.
  • Over the past 5 years, Amgen's EBT Margin (Quarter) stood at 31.13% in 2021, then fell by -18bps to 25.56% in 2022, then tumbled by -59bps to 10.4% in 2023, then decreased by -17bps to 8.61% in 2024, then soared by 377bps to 41.03% in 2025.
  • Its last three reported values are 41.03% in Q3 2025, 17.08% for Q2 2025, and 24.21% during Q1 2025.